Skip to main content

Catalyst Calendar

Wed, Sep 16, 2026

1 updates

7:00 AM

Insmed Expands Community Impact During Fifth Annual Global Day of Good

insmed.com

Fri, Sep 4, 2026

1 updates

7:00 AM

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

insmed.com

Thu, Sep 3, 2026

1 updates

7:00 AM

Insmed to Present Data Across Its Respiratory Portfolio, Including New Late-Breaking ARIKAYCE® (amikacin liposome inhalation suspension) Results From Phase 3b ENCORE Study at the European Respiratory Society Congress 2026

Presentation / Abstract • Phase 3ERS oral presentation Sun, Sep 6, 2026, 9:30 AM CESTinsmed.com

Wed, Aug 26, 2026

1 updates

7:00 AM

Insmed to Present at September 2026 Investor Conferences

insmed.com

Mon, Aug 24, 2026

1 updates

7:00 AM

BRINSUPRI® (brensocatib) Approved by Japan's Ministry of Health, Labour and Welfare for the Treatment of Patients With Non-Cystic Fibrosis Bronchiectasis, a Serious, Chronic Lung Disease

insmed.com

Thu, Aug 6, 2026

1 updates

7:00 AM

Insmed Reports Second-Quarter 2026 Financial Results and Provides Business Update

insmed.com

Thu, Jul 23, 2026

1 updates

7:00 AM

Insmed to Host Second-Quarter 2026 Financial Results Conference Call on Thursday, August 6, 2026

insmed.com

Thu, Jul 16, 2026

1 updates

7:00 AM

Insmed Announces Positive 12-Month Data from the Ongoing Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Patients with Pulmonary Arterial Hypertension

Results Call • Phase 2Results call Thu, Jul 16, 2026, 8:00 AM ETinsmed.com

Tue, Jun 23, 2026

1 updates

7:00 AM

Insmed Appoints Samuele Butera as Senior Vice President, General Manager, Global Respiratory

insmed.com